Ascletis Files Two FDA IND Applications for Long-A...
Category : Product Related Updates 6 July 2026Ascletis Pharma Inc. has announced the submission of two Investigational New Drug (IND) applications...
Ascletis Pharma Inc. has announced the submission of two Investigational New Drug (IND) applications...
For decades, motion sickness treatments barely evolved. That changes now. Vanda Pharmaceuticals has...
Physician-dispensed brand Revision Skincare has released two peer-reviewed clinical studies in the J...
Emcure Pharmaceuticals Ltd., a leading Indian pharma company, has announced the price revision of it...
A new treatment option has entered the European market for one of the most challenging post-transpla...